- Home
- CHRS vs RELL Comparison
CHRS vs RELL Comparison
Compare CHRS & RELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- RELL
- Stock Information
- Founded
- CHRS 2010
- RELL 1947
- Country
- CHRS United States
- RELL United States
- Employees
- CHRS N/A
- RELL N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- RELL Electronic Components
- Sector
- CHRS Health Care
- RELL Technology
- Exchange
- CHRS Nasdaq
- RELL Nasdaq
- Market Cap
- CHRS 159.2M
- RELL 139.9M
- IPO Year
- CHRS 2014
- RELL N/A
- Fundamental
- Price
- CHRS $1.35
- RELL $9.99
- Analyst Decision
- CHRS Strong Buy
- RELL
- Analyst Count
- CHRS 4
- RELL 0
- Target Price
- CHRS $4.51
- RELL N/A
- AVG Volume (30 Days)
- CHRS 1.2M
- RELL 38.7K
- Earning Date
- CHRS 11-05-2025
- RELL 10-08-2025
- Dividend Yield
- CHRS N/A
- RELL 2.35%
- EPS Growth
- CHRS N/A
- RELL N/A
- EPS
- CHRS 1.55
- RELL N/A
- Revenue
- CHRS $272,209,000.00
- RELL $208,909,000.00
- Revenue This Year
- CHRS N/A
- RELL $3.90
- Revenue Next Year
- CHRS $109.48
- RELL $15.83
- P/E Ratio
- CHRS $0.87
- RELL N/A
- Revenue Growth
- CHRS 52.33
- RELL 6.34
- 52 Week Low
- CHRS $0.66
- RELL $7.57
- 52 Week High
- CHRS $2.43
- RELL $15.51
- Technical
- Relative Strength Index (RSI)
- CHRS 64.99
- RELL 53.38
- Support Level
- CHRS $1.23
- RELL $9.48
- Resistance Level
- CHRS $1.40
- RELL $9.95
- Average True Range (ATR)
- CHRS 0.08
- RELL 0.29
- MACD
- CHRS -0.00
- RELL 0.05
- Stochastic Oscillator
- CHRS 72.13
- RELL 59.46
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About RELL Richardson Electronics Ltd.
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. Its products have applications in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The company segments include PMT (Power and Microwave Technologies Group), Canvys, (Green Energy Solutions) GES, and Healthcare reportable segments. The company derives the majority of its revenues from the PMT segment.